Articles tagged with Antibiotics
Researchers at the University of Illinois have discovered a new enzyme that can create antibiotic compounds by nature's machinery. This breakthrough could lead to the development of new antibiotics and combat antimicrobial resistance.
Linezolid has been shown to be effective in treating diabetic foot infections with a clinical cure rate of 81%. The drug can be given orally or intravenously, making it suitable for outpatient use. This approval may reduce hospitalizations and IV-related complications among patients with diabetic foot infections.
Researchers found that antibiotics improve daily growth and reduce swine death rates, resulting in higher profit returns for farmers. The study suggests that a ban on antibiotic use would lead to sharp increases in production costs.
Researchers in Switzerland discovered a high level of antibiotic resistance in Campylobacter bacteria, which causes 5-14% of diarrheal illnesses globally. The study found that 59% of isolated strains were sensitive to all tested antibiotics, while some were resistant to multiple antibiotics, posing concerns for public health.
A study published in Nature reveals a genetic approach that may help combat antibiotic-resistant biofilms, which are involved in 65% of human bacterial infections. The researchers identified a mutant strain of Pseudomonas aeruginosa that is more sensitive to antibiotics, providing a potential solution for diseases like cystic fibrosis.
A prospective study in Botswana found that only 1.8% of asymptomatic HIV-infected outpatients with preventive therapy developed TB, rendering routine chest radiography unnecessary for screening in settings where signs and symptoms can be effectively identified.
An asthma intervention study showed a 60% reduction in total hospitalizations among patients with frequent asthma exacerbations. Researchers also found that initial use of three antibiotics followed by diagnostic testing led to better patient survival and reduced antibiotic use for ventilator-associated pneumonia. Additionally, prematu...
A new study published in The Lancet found that pulse-dye laser therapy (PDL) was effective in reducing acne symptoms by half at three months. PDL treatment was also well-tolerated and showed the largest effect within four weeks, suggesting it could be a promising alternative to daily conventional pharmacological treatments.
A new study found that administering antibiotics in a syringe pump, rather than by direct injection, can significantly reduce costs. The study also showed that the most expensive antibiotic to administer was Erythromycin, which requires slow infusion time.
Research reveals that bone cement containing antibiotics can effectively control bacterial growth in the immediate vicinity of the implant, but this effectiveness is short-lived. After just a few weeks, the concentration of antibiotics decreases, making it less effective against bacteria.
A recent study by Henry Ford Health found a significant link between early antibiotic use in children and an increased risk of developing allergies and asthma. The study followed 448 children from birth to seven years and found that those who received antibiotics in the first six months were more likely to develop these conditions.
A randomized trial found that selective use of antibiotic decontamination (SDD) significantly reduced ICU deaths by 15% and overall hospital deaths by 24%, as well as infection rates with antibiotic-resistant bacteria by 16%. The study advocates for the use of SDD in patients on mechanical ventilation or in ICUs with low prevalence of ...
Researchers at University of Wisconsin-Madison uncover a potent toxin reveals new antibiotic resistance mechanism, where bacteria deploy a protein to intercept and inactivate the toxin. This mechanism points to the fact that bacteria continue to find new routes to evade antibiotics, threatening the fight against deadly bacteria.
A study of children with Medicaid insurance found that they received antibiotics for only 41% of the year, despite being at risk for nearly 60% of the time. The lack of antibiotic use puts these children at high risk of developing serious infections and sometimes dying.
A new anthrax inhibitor being researched by Rensselaer Polytechnic Institute may be able to prevent the toxin from binding to human cells, thereby hindering its damage. This breakthrough could enable successful treatment of anthrax at later stages and save more lives.
A new study found that larger exposures to anthrax spores require longer antibiotic therapy. In low-exposure cases, sixty days of antibiotics provide adequate protection, but four months are needed for high-exposure situations.
A randomized pilot study found that alternating two triple-drug regimens every three months significantly reduced drug failure and kept the viral load suppressed. However, a cost-effectiveness study identified four strategies to determine if a sore throat is caused by bacterial infection, reducing inappropriate antibiotic use.
The UK is experiencing an increased rate of gonorrhoea infection due to growing antibiotic resistance, particularly with ciprofloxacin. The Health Protection Agency recommends reviewing national and local treatment guidelines to ensure effective treatment using alternative antibiotics such as cephalosporins or spectinomycin.
Researchers have isolated a potent antifungal compound from the common seaweed species Lobophora variegata, revealing an unusual chemical structure. This discovery presents new insights into ecological interactions between marine organisms and offers possibilities for biomedical applications.
Researchers at NYU Langone Health have found that the new antibiotic linezolid is effective against multidrug-resistant tuberculosis (TB), a disease that affects millions worldwide. The drug was administered to five patients who had run out of other treatment options, and all showed significant improvement.
Researchers have discovered how bacteria evade antibiotics by exploiting a protein complex with a diverse binding site. The findings may lead to the development of new antibiotics that can bypass this pump, allowing drugs to kill bacteria. Alternative strategies, such as disabling the pump, are also being explored.
A randomized trial found that patients with early Lyme disease and no heart, joint or neurologic abnormalities can be effectively treated with 10 days of doxycycline therapy. The study showed that approximately two-thirds of patients responded to treatment within 20 days.
Researchers at Cardiff University discovered that inflating urinary catheters with a solution of triclosan inhibits the formation of crystalline biofilm, preventing blockages. The method could have practical applications in controlling catheter encrustation and treating urinary tract infections.
Researchers create vancomycin conjugates with buckyballs, which can target specific bacterial antigens and potentially treat resistant strains. The conjugates could also be used to prevent anthrax spores from germinating, offering a new defense against bioterrorism.
The researchers propose a four-pronged approach to avoid a catastrophe: decisive action by authorities, immediate antibiotic distribution, clear messaging about the need for full treatment courses, and surge capacity for medical professionals. This could reduce the death toll from an anthrax attack from 123,000 to 1,000.
Researchers developed a treatment strategy that combines antibiotics to kill infection with protective antigen antibodies to prevent toxin damage, achieving 100% survival in animal models. The approach addresses the limitations of current antibiotic-only treatments, which only cure 50% of infected animals.
Walsh's research team has focused on developing selective antibiotics that target bacterial enzymes while leaving human ones intact. His work has helped design new variants of vancomycin, some of which are now in human trials to combat antibiotic-resistant bacteria.
Researchers found that high-risk trachoma patients are unwilling to pay for future antibiotics, even if they can use household items as payment. This could limit the government's ability to control the disease and its progression.
A new study by U-M researchers found that the common cold leads to significant economic impact, with Americans spending over $2.9 billion on over-the-counter drugs and nearly $1.1 billion on antibiotic prescriptions for symptomatic relief. The total economic cost of cold-related work loss exceeds $20 billion annually.
Cecropin A alters bacterial gene regulation, challenging conventional thinking on its mechanism of action. The insect antibiotic's ability to evade resistance raises hope for new therapeutic agents.
A new compound has been discovered that can inhibit the formation of biofilms in bacteria, which are often lethal to patients with compromised immune systems. The compound works by disrupting quorum sensing, a process that allows bacterial cells to communicate and mount an effective attack.
Research explores whether animal antibiotics contribute to rising human resistance rates. The study finds that animal antibiotics can indeed fuel human antibiotic resistance, highlighting the need for stricter regulations on their use.
Researchers at the University of Florida have developed a novel approach to curing mice of Vibrio vulnificus, a deadly bacteria that causes flu-like symptoms and can be fatal. The treatment involves using a virus to attack the bacterial source, showing promise as an alternative to antibiotics for treating this disease.
A new study has identified azithromycin as an effective single-dose antibiotic treatment for children with cholera, reducing diarrhoea duration by 24 hours compared to erythromycin. However, the high cost of azithromycin may limit its widespread adoption in treating childhood cholera.
Research suggests that honey's antibacterial properties can inhibit a range of strains, including MRSA, VSE, and VRE. This study indicates a possible role for honey in the treatment of wounds colonised by antibiotic-resistant bacteria.
A new study finds that linezolid is as effective as vancomycin in treating infants and children with gram-positive infections, providing a valuable treatment option for this age group. The antibiotic is particularly promising for community-acquired MRSA infections, which are becoming increasingly difficult to manage.
Resistant strains of Staphylococcus aureus, also known as hospital staph, have become increasingly prevalent worldwide. Researchers have identified key differences in the structure of penicillin-binding protein 2A (PBP2a), which enables it to resist beta-lactam antibiotics.
A recent study reveals that asthma affects over 42,000 US households, with moderate to severe persistent disease prevalent among individuals. Additionally, the research highlights the significant impact of asthma on daily activities, affecting two-thirds of respondents.
A new study suggests that antibiotics are not always beneficial for childhood ear infections, with some cases clearing up on their own. The review also found that giving children a flu shot can reduce the likelihood of otitis by 30 percent during flu season.
Researchers at Los Alamos National Laboratory have developed a computer model of the E-coli ribosome, a cellular structure responsible for protein creation. This model has applications in developing new and powerful antibiotics against a range of pathogens, including those used in bioweapons agents.
The TRUST 2002 study found high resistance rates to penicillin (18.4%) and azithromycin (27.5%), but low levofloxacin resistance (<1%). Levofloxacin's minimal inhibitory concentrations did not correlate with those of other antibiotics.
A study found that azithromycin improved forced expiratory volume in one second's exhalation (FEV1) by around 5% in some children with cystic fibrosis. The drug was well-tolerated and showed no significant difference in quality-of-life assessments compared to placebo.
A study of 24,690 British children found a dose-related association between maternal antibiotic exposure during pregnancy and increased risk of asthma, eczema, and hay fever. Another study on Alaskan sled dogs suggests that 'ski asthma' may be a model for exercise-induced airway injury in humans.
Research by Colleen Flaherty reveals pharmaceuticals can stunt growth and result in more male offspring in Daphnia, while combination effects can be lethal. The study highlights the need to consider multiple chemicals in assessing ecological impacts.
A rapid test developer suggests a PCR-based approach as an effective alternative to current methods for detecting group A streptococcus in throat swabs. The proposed test offers enhanced sensitivity and faster results compared to traditional antigen testing.
Researchers found significant effects of air pollution on children's lung function growth rates, with acid vapor showing the most consistent effect. A separate study found no association between antibiotic use in early life and asthma development at age 5.
Regular cranberry juice consumption could reduce UTI development and need for antibiotics, potentially slowing antibiotic resistance. Cranberry's anti-adhesion properties prevent bacteria from sticking to the urinary tract.
Researchers found that mupirocin antibiotic ointment can significantly reduce the rate of Staphylococcus aureus surgical wound infections in patients undergoing elective surgery. The study's results have significant implications for reducing hospital-based infections and preventing illnesses, especially in vulnerable populations.
Researchers found that antibiotic treatment improved lung function in 56% of mild to moderate asthmatics with evidence of Mycoplasma pneumoniae or Chlamydia pneumoniae infections. Lung function also showed improvement after treatment, with an average increase of 200 milliliters.
Scientists from Johns Hopkins Medicine have discovered that sulforaphane, a compound found in broccoli, kills the bacterium Helicobacter pylori, which causes stomach cancers and ulcers. The findings suggest that dietary intake of vegetables containing sulforaphane could relieve infection and have significant public health implications.
Researchers discovered that ramoplanin effectively targets bacteria's ability to build cell walls, dodging common mechanisms of mutational resistance. This finding could lead to the development of new classes of antibiotics for treating drug-resistant infections.
A new study published in the American Journal of Obstetrics and Gynecology found that outpatient antibiotic treatment for PID is just as effective as inpatient treatment. The study, known as PEACH, involved 831 women with PID and showed no significant differences in outcomes between those treated inpatient or outpatient.
A UCLA study found that despite efforts to educate parents, 55% of antibiotic prescriptions for respiratory illnesses are unnecessary. The research also showed that doctors are more likely to prescribe antibiotics if they sense parent expectation, highlighting the need for better communication and culturally appropriate education.
Researchers analyzed data from people who received a 60-day antibiotic regimen after exposure to potentially contaminated mail and handling facilities. They found that twice as many people may have contracted inhalational anthrax without receiving the treatment, suggesting the risk is very small.
Bacteria use transporters to pump iron into cells, a process that could be exploited for new antibiotic designs. Researchers deciphered the structure of an iron transporter and found it undergoes dramatic changes when transporting iron.
Biologists at Princeton University discovered a protein that initiates biofilm formation in E. coli bacteria, using a 'touch sensor' mechanism to sense solid surfaces. This finding suggests disrupting this sensing mechanism could be an effective strategy for developing new antibacterial agents targeting biofilms.
Researchers have learned how bacteriophage T4 uses a needle-like device to infect its host E. coli, potentially leading to new antibiotic tools. The baseplate portion of the virus tail is essential in this process and could help create 'designer viruses' with improved infectivity.
Researchers discover antimicrobial peptides in plants and animals, which target bacterial membranes to defend against infections. The study reveals these molecules provide a natural solution to combat growing antibiotic resistance.
Researchers found that inhibiting acid production made stomachs more vulnerable to bacterial invasion and gastritis. The study suggests that antibiotics are the best way to kill bacteria causing gastritis and eliminate inflammation. Inhibiting acid production can actually trigger an inflammatory response, making gastritis worse.
A study found that only 24% of antibiotics prescribed for women's urinary tract infections are the recommended drug, down from 48% in 1990. The alternative medications are no more effective and cost 11-40 times as much. This trend appears to result from non-clinical forces such as pharmaceutical promotions and sub-specialty culture.